# Confirm Performance and Safety of Exufiber When Used as Intended on Donor Sites

> **NCT04884568** · NA · COMPLETED · sponsor: **Molnlycke Health Care AB** · enrollment: 34 (actual)

## Conditions studied

- Acute Wound
- Donor Site
- Split Skin Graft

## Interventions

- **DEVICE:** Exufiber

## Key facts

- **NCT ID:** NCT04884568
- **Lead sponsor:** Molnlycke Health Care AB
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-11-16
- **Primary completion:** 2023-05-09
- **Final completion:** 2023-05-09
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2023-09-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04884568

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04884568, "Confirm Performance and Safety of Exufiber When Used as Intended on Donor Sites". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04884568. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*